As per DelveInsight's analysis, the total market size of BAFF- and APRIL-targeted therapies in the 7MM is expected to surge significantly by 2034. BAFF and APRIL-targeted therapies are actively being ...

SAN FRANCISCO and VANCOUVER, British Columbia, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (the ”Company” or “Jade”) (Nasdaq: JBIO), a clinical-stage biotechnology company focused on ...

Multiple sclerosis (MS) is recognized as one of the most prevalent neurological diseases among young adults, with symptoms typically emerging between ages 20 to 40 years. The condition is ...

B-cell-activating factor (BAFF) is a member of the tumour-necrosis factor (TNF) family. BAFF is a trimeric membrane-bound or soluble factor that binds to three receptors — BCMA (B-cell maturation ...

Squishy Baff promises to turn regular bath water into goo, but does it work? In this edition of FOX8 On Your Side, Consumer Reporter Melissa Painter puts the Squishy Baff to the Deal or Dud test.

We aimed to characterize the role of B-cell activating factor (BAFF) in macrophage-mediated resistance of multiple myeloma (MM) cells to bortezomib (bort), and to further understand the molecular ...

Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — Multiple potentially new therapies promise to improve the management of patients with Sjogren’s ...

Genomewide association studies of autoimmune diseases have mapped hundreds of susceptibility regions in the genome. However, only for a few association signals has the causal gene been identified, and ...